An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Human papillomavirus (HPV) has been identified as a necessary factor in the development
of pre-invasive and invasive cancers of the lower genital tract, of which cervical cancer is the …

Importance Evidence on the relative benefits and harms of primary high-risk human
papillomavirus (hrHPV) testing is needed to inform guidelines. Objective To inform the US …

External genital warts, also known as condylomata acuminata, are extremely common, with
between 500,000 to one million new cases diagnosed each year in the United States alone …

Background The increases in STI rates since the late 1990s in Canada have occurred
despite widespread primary care and targeted public health programs and in the setting of …

Cervical cancer is the third most common cause of cancer in women in the world. During the
past few decades tremendous strides have been made toward decreasing the incidence …

Cervical cancer is the main cancer among women in sub‐Saharan Africa, India and other
parts of the developing world. Evaluation of screening performance of effective, feasible and …

A group of 146 experts representing 29 organizations and professional societies met
September 18-19, 2006, in Bethesda, MD, to develop revised evidence-based, consensus …

This paper briefly reviews the role of hypermethylation of host cell genes in cervical
carcinogenesis and discusses potential clinical applications of methylation analysis in the …